SAN ANTONIO, TX, Sept. 26, 2018 /CNW/ - Alternate Health Corp., ("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international leader in software solutions for the medical cannabis industry, announced today the launch of its FlorPass medical cannabis online shopping portal with Liberty Health Sciences in Florida.
"With the launch of the system's e-commerce and digital transaction features, FlorPass is transforming how patients shop for their medical cannabis online," says Dr. Michael Murphy, Chairman and CEO of Alternate Health. "As the only medical cannabis e-commerce system approved by the Florida Department of Health, we have established an innovative model with the ability to capture the statewide market for digital cannabis transactions."
Alternate Health and Liberty Health Sciences gained approval from the Florida Department of Health in August to offer medical cannabis e-commerce features. The FlorPass online shopping portal has launched for certified patients in St. Petersburg and Tampa with plans to quickly expand to additional locations before the end of October.
"We are excited to be the first in Florida to provide FlorPass, a cutting edge, secure online shopping experience for our diverse collection of premium cannabis products," said George Scorsis, CEO of Liberty Health Sciences. "This is not only a functional way to do transactions, FlorPass will help us grow our business by building better relationships with our patients and enhance overall patient satisfaction. We will continue to invest in state-of-the-art technology to support the development of our products and remain committed to providing guidance and continued care throughout the entire patient experience."
Alternate Health anticipates strong revenue potential from FlorPass and is aggressively expanding its market presence throughout Florida. FlorPass is the first-mover for medical cannabis e-commerce in the state, following the activation of digital transaction capabilities, which positions the Company to take the lead in developing this promising market.
The FlorPass Electronic Medical Records ("EMR") platform launched in clinics and doctor's offices throughout Florida in 2017, quickly gaining support from the state's medical community. Following a strong endorsement from the American Medical Marijuana Physicians Association (AMMPA), Alternate Health rapidly onboarded new physicians, clinics and patients. As of September 2018, FlorPass has over 7,500 patients registered in the system.
With innovative security and compliance features, FlorPass greatly increases the efficiency of the Florida medical cannabis industry. The system offers patients, producers and regulators a full suite of digital tools to manage and facilitate all transactions within Florida's medical cannabis economy. As a cloud-based, blockchain platform, FlorPass is easily scalable to capture market share throughout Florida.
Liberty is the cannabis provider committed to providing a trusted, high quality cannabis experience because of our genuine care for all cannabis users and a focus on operational excellence from seed to sale and beyond. Liberty's stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near-and mid-term opportunities while keeping consumers' well-being at the forefront of what we do. Liberty has an extensive background in highly regulated industries and leverages its commercial greenhouse expertise to drive low-cost production. For more information, please visit: www.libertyhealthsciences.com
FlorPass is a blockchain-enabled software platform that manages the end-to-end transactions involved in providing safe access to medical cannabis to eligible patients. The system provides secure access to patients, physicians and licensed dispensaries, all linked through a seamless interface, with the ability to process medical cannabis transactions and facilitate enhanced medical treatment recommendations, focused on improving patient outcomes.
Approved by the Florida Department of Health and endorsed by the American Medical Marijuana Physicians Association, FlorPass is the state's first online shopping portal for medical cannabis equipped with digital transaction capabilities.
About Alternate Health
Alternate Health Corp. (CSE: AHG, OTCQB: AHGIF) Alternate Health has established multiple arms-length operations within the medical cannabis industry, each of which drives consumers, data and strategic opportunities to the company's other verticals. Through its software solutions, data analytics and patented delivery systems, Alternate Health's goal is to be the global authority on scientific and clinical support for cannabis in regulated markets. Alternate Health is well positioned to reinvest internal operating cash flow in its platform over the long term, creating an attractive investment profile for its shareholders.
Alternate Health resides in the cannabis sector along with companies like GW Pharmaceuticals, AXIM Biotechnologies Inc., Canopy Growth Corporation, and Aphria Inc. Alternate Health is differentiated from other cannabis companies by its focus on ancillary services for patients, healthcare professionals and regulatory providers rather than selling a commodity. For more information about Alternate Health Corp., visit www.alternatehealth.ca.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as "forward-looking statements". Forward-looking statements may be identified by words including "anticipates", "believes", "intends", "estimates", "expects" and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company's future operations, business prospects, anticipated lab sample increases and potential revenues, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements.
SOURCE Alternate Health Corp.
For further information: Investor Relations Contact: Jim Griffiths, Director, 1.416.607.5757, [email protected]